Authors:
MARINO MJ
ROUSE ST
LEVEY AI
POTTER LT
CONN PJ
Citation: Mj. Marino et al., ACTIVATION OF THE GENETICALLY DEFINED M1 MUSCARINIC RECEPTOR POTENTIATES N-METHYL-D-ASPARTATE (NMDA) RECEPTOR CURRENTS IN HIPPOCAMPAL PYRAMIDAL CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(19), 1998, pp. 11465-11470
Citation: Sl. Purkerson et Lt. Potter, USE OF ANTIMUSCARINIC TOXINS TO FACILITATE STUDIES OF STRIATAL M4 MUSCARINIC RECEPTORS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 707-713
Authors:
CARSIGABRENAS JM
VANDERZEE EA
LUITEN PGM
POTTER LT
Citation: Jm. Carsigabrenas et al., NON-SELECTIVITY OF THE MONOCLONAL-ANTIBODY M35 FOR SUBTYPES OF MUSCARINIC ACETYLCHOLINE-RECEPTORS, Brain research bulletin, 44(1), 1997, pp. 25-31
Authors:
WATSON EL
ABEL PW
DIJULIO D
ZENG W
MAKOID M
JACOBSON KL
POTTER LT
DOWD FJ
Citation: El. Watson et al., IDENTIFICATION OF MUSCARINIC RECEPTOR SUBTYPES IN MOUSE PAROTID-GLAND, American journal of physiology. Cell physiology, 40(3), 1996, pp. 905-913
Citation: Si. Max et al., PURIFICATION AND PROPERTIES OF M1-TOXIN, A SPECIFIC ANTAGONIST OF M1 MUSCARINIC RECEPTORS, The Journal of neuroscience, 13(10), 1993, pp. 4293-4300
Citation: Si. Max et al., USE OF M1-TOXIN AS A SELECTIVE ANTAGONIST OF M1-MUSCARINIC RECEPTORS, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 480-485
Citation: Bd. Pearce et al., EFFECT OF CHRONIC CHOLINERGIC DENERVATION ON THE M1 MUSCARINIC RECEPTOR MECHANISM, Neurobiology of aging, 13(2), 1992, pp. 293-299